Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05558566 · ClinicalTrials.gov registry record · NA
Neurofeedback From the Supplementary Motor Area for Tourette Syndrome
A NA study of Tourette Syndrome in Adolescence, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT05558566: Recruiting NA study of Tourette Syndrome in Adolescence, sponsored by Yale University.
NCT05558566 is a NA study of Tourette Syndrome in Adolescence that is actively recruiting participants, run by Yale University. The registered enrollment target is 64 participants, above the 35-participant average among 5 other Tourette Syndrome in Adolescence trials with a reported enrollment target (83% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05558566, a NA study of Tourette Syndrome in Adolescence, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a clinical trial where adolescents aged 10-16 years old with Tourette Syndrome (or chronic tic disorder) are randomized to receive either real-time functional magnetic resonance imaging (fMRI) neurofeedback targeting the supplementary motor area (for the experimental intervention) or real-time fMRI neurofeedback (NF) from a control region (for the control intervention).
Primary Outcome
Symptom severity is assessed using the Yale Global Tic Severity Scale (YGTSS) before NF and at several time points in the month following the completion of NF training.
Conditions Studied
Interventions
- OTHER Neurofeedback from the SMA
- OTHER Neurofeedback from control region
Study Locations (1)
Connecticut
- Yale University School of Medicine - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2027-01-20 |
| Phase | NA |
What NCT05558566 shows while recruiting
NCT05558566 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, above the 35-participant average among 5 other Tourette Syndrome in Adolescence trials with a reported enrollment target (83% higher).
The record links to 1 condition, with Tourette Syndrome in Adolescence appearing as the primary indexed condition, and to 2 interventions - of which Neurofeedback from the SMA is the first listed.
NCT05558566 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT05558566 about?
NCT05558566 is a clinical study titled "Neurofeedback From the Supplementary Motor Area for Tourette Syndrome". This is a clinical trial where adolescents aged 10-16 years old with Tourette Syndrome (or chronic tic disorder) are randomized to receive either real-time functional magnetic resonance imaging (fMRI) neurofeedback targeting the supplementary motor area (for the experimental intervention) or real-ti...
What is the current status of trial NCT05558566?
This trial is currently recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2022-11-01. Estimated completion is 2027-01-20.
What conditions does trial NCT05558566 study?
This clinical trial studies the following conditions: Tourette Syndrome in Adolescence.
What interventions are being tested in trial NCT05558566?
The interventions under investigation include: Neurofeedback from the SMA (OTHER), Neurofeedback from control region (OTHER).
Who is sponsoring clinical trial NCT05558566?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05558566 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tourette Syndrome in Adolescence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Characteristics and Temporal Properties of Individual Tics in Persistent Tic Disorder
RECRUITING · NA
-
Investigating Changes in Premonitory Urges During Habit Reversal Training for Tics
RECRUITING · NA
-
Transcranial Magnetic Stimulation to Augment Behavior Therapy for Tics
COMPLETED · NA
-
Influence of Stress and Psychiatric Symptoms on Children With Tourette Syndrome
COMPLETED
-
Tourette Discrimination (TD) Stigma Scale
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI